Skip Navigation



Rheumatology Advance Access published online on April 1, 2008
Rheumatology, doi:10.1093/rheumatology/ken088
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
47/5/739    most recent
ken088v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Slusher, J. R.
Right arrow Articles by Lozada, C. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Slusher, J. R.
Right arrow Articles by Lozada, C. J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Central nervous system Aspergillus fumigatus presenting as cranial nerve palsy in a patient with ankylosing spondylitis on anti-TNF therapy

J. R. Slusher1, M. E. Maldonado2,3, F. Mousavi1 and C. J. Lozada2,4

1University of Miami/Jackson Memorial Medical Center, 2University of Miami Miller School of Medicine, 3Miami Veterans Affairs Medical Center and 4Rheumatology Clinical Services, Jackson Memorial Hospital, Miami, FL, USA

Correspondence to: C. J. Lozada, 1120 N.W. 14th Street, Suite 973, Miami, FL 33136, USA. E-mail: clozada@med.miami.edu

The first 10% of the full text of this article appears below.

SIR, A 52-yr-old black male with a 4-yr history of AS and mild apical pulmonary fibrosis previously responsive only to oral corticosteroids was started on etanercept 25 mg subcutaneously twice a week with excellent clinical response.

At 18 months of treatment with etanercept, the patient developed fevers, weight loss and night sweats. Etanercept therapy was immediately discontinued and work-up initiated for possible infectious aetiology. Prednisolone 12.5 mg/day and NSAIDs were continued.

The patient then developed right-sided facial pain and a sensation of inner-ear pressure with . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?